These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 31121458)

  • 1. Tobacco Control in Oman: It's Time to Get Serious!
    Al-Lawati J; Mabry RM; Al-Busaidi ZQ
    Oman Med J; 2017 Jan; 32(1):3-14. PubMed ID: 28042396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessing policy paradigms: A comparison of the global tobacco and alcohol industries.
    Hawkins B; Holden C; Eckhardt J; Lee K
    Glob Public Health; 2018 Jan; 13(1):1-19. PubMed ID: 26998944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review on the progress of tobacco epidemic monitoring methods].
    Liu WZ; Liu SW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1661-1666. PubMed ID: 37875457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological Model for Conventional Tobacco Control Measures and Tobacco Endgame Policies.
    Kang H; Cho SI
    J Prev Med Public Health; 2023 Sep; 56(5):481-484. PubMed ID: 37828875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WHO MPOWER Package and the Tobacco Control Scale: Two Tools to Monitor Country-level Tobacco Control Policy Implementation in Latin America.
    Feliu A; Martinez C; Peruga A; Fernandez E
    Arch Bronconeumol; 2023 Nov; 59(11):785-786. PubMed ID: 37714765
    [No Abstract]   [Full Text] [Related]  

  • 6. Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan.
    Yang SL; Togawa K; Gilmour S; Leon ME; Soerjomataram I; Katanoda K
    Tob Control; 2024 Apr; 33(3):295-301. PubMed ID: 36100264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and Determinants of Cigarette Tax Increases in Japan: The Role of Revenue Targeting.
    Oshio T; Nakamura R
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heated tobacco product use, its correlates, and reasons for use among Mexican smokers.
    Cruz-Jiménez L; Barrientos-Gutiérrez I; Zavala-Arciniega L; Arillo-Santillán E; Gallegos-Carrillo K; Rodríguez-Bolaños R; Gravely S; Thrasher JF
    Drug Alcohol Depend; 2022 Mar; 232():109283. PubMed ID: 35134734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a third term of Health Japan 21 - implications from the rise in non-communicable disease burden and highly preventable risk factors.
    Nomura S; Sakamoto H; Ghaznavi C; Inoue M
    Lancet Reg Health West Pac; 2022 Apr; 21():100377. PubMed ID: 35098183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Report on Smoking and Infection Control Behaviours at Outdoor Hotspots during the COVID-19 Pandemic: An Unobtrusive Observational Study.
    Sun Y; Lam TH; Cheung YTD; Wang MP; Wu Y; Chen J; Zhang X; Li WHC; Ho SY
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey Methods of the 2018 International Tobacco Control (ITC) Japan Survey.
    Thompson ME; Boudreau C; Quah ACK; Ouimet J; Li G; Yan M; Mochizuki Y; Yoshimi I; Fong GT
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Daily and Non-Daily Use of Heated Tobacco Products with Combustible Cigarettes: Findings from the 2018 ITC Japan Survey.
    Sutanto E; Miller C; Smith DM; Borland R; Hyland A; Cummings KM; Quah ACK; Xu SS; Fong GT; Ouimet J; Yoshimi I; Mochizuki Y; Tabuchi T; O'Connor RJ; Goniewicz ML
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32235702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new craving index for anticipating quitting smoking in patients who undergo the Japanese smoking cessation therapy.
    Taniguchi C; Tanaka H; Nakamura S; Saito S; Saka H
    Tob Induc Dis; 2019; 17():89. PubMed ID: 31892919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities for greater tobacco control in Japan.
    Tanigaki J; Poudyal H
    Int J Drug Policy; 2019 Aug; 70():78-86. PubMed ID: 31121458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014.
    Levy DT; Yuan Z; Luo Y; Mays D
    Tob Control; 2018 Jan; 27(1):50-57. PubMed ID: 27956650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tobacco control in Japan: what it is, and what it should be].
    Sakuta M
    Nihon Rinsho; 2013 Mar; 71(3):399-405. PubMed ID: 23631226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Tobacco Industry Interference Index (TIII) and MPOWER measures and adult daily smoking prevalence rate in 30 countries.
    Lee Y; Kim S; Kim MK; Kawachi I; Oh J
    Global Health; 2024 Jan; 20(1):6. PubMed ID: 38172937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Courtesy and the challenges of implementing smoke-free policies in Japan.
    Bialous SA; Mochizuki-Kobayashi Y; Stillman F
    Nicotine Tob Res; 2006 Apr; 8(2):203-16. PubMed ID: 16766413
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.